Lot Release Certificate View

Lot Release Number 2022-06-02-0138
FDA Registered Product/Generic Name DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B, POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED) [DTAP-IPV-HEPB-HIB]
Brand Name HEXAXIM
Dosage Strength 0.5 mL
Dosage Form SUSPENSION FOR INJECTION (I.M.)
Registration Number BR-919
Batch/Lot Number U3L61
Packaging Lot Packaging Lot (Box): U3L611V; (PFS): U3L61; (Needle 25G x 5/8"): 2101035; (Needle 25G x 1"): 2012007
Product Expiration Date 31 May 2023
Issuance Date 8 June 2022